Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Giorgio Mustacchi & Michelino De Laurentiis. (2015) The role of taxanes in triple-negative breast cancer: literature review. Drug Design, Development and Therapy 9, pages 4303-4318.
Read now
Read now
Articles from other publishers (3)
Fengchang Zhu, Chengyin Liu, Huaji Zhang & Liping Bai. (2022) Efficacy and Safety of Albumin-bound Paclitaxel Versus Solvent-based Paclitaxel in Breast Cancer: A Meta-analysis. Journal of Modern Nanotechnology 2:1.
Crossref
Crossref
Yifan Xie, Siyu Wu, Ying Zhang, Jianwei Li, Miao Mo, Zhimin Shao & Guangyu Liu. (2021) Optimal Duration of Neoadjuvant Taxane and Carboplatin Combined With Anti-HER2 Targeted Therapy for HER2-Positive Breast Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Yu Zong, Jiayi Wu & Kunwei Shen. (2017) Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysis. Oncotarget 8:10, pages 17360-17372.
Crossref
Crossref